搜索临床试验以:TAS5315 剂量 4
总计10256个结果
-
Michigan State UniversityHenry Ford Health System; Butler Hospital; Pacific Institute for Research and Evaluation招聘中
-
University Hospital, Strasbourg, France终止
-
City of Hope Medical CenterNational Cancer Institute (NCI)完全的
-
Institute of Medical Biology, Chinese Academy of...Guangxi Center for Disease Control and Prevention完全的
-
Sierra Oncology, Inc.完全的原发性骨髓纤维化 (PMF) | 原发性血小板增多症后骨髓纤维化(ET 后 MF) | 真性红细胞增多症后(后 PV)美国, 加拿大, 法国, 意大利, 德国, 西班牙, 以色列, 英国
-
Kessler FoundationNational Institute on Disability, Independent Living, and Rehabilitation Research; Acorda Therapeutics完全的
-
HRH Pharmaceuticals LimitedGALZU INSTITUTE OF RESEARCH, TEACHING, SCIENCE AND APPLIED TECHNOLOGY, Brazil; Clinical Research...完全的
-
University of California, San FranciscoNational Institute on Aging (NIA); Alzheimer's Association; Posit Science Corporation; YMCA of San...完全的
-
University Hospital OstravaInstitute for Clinical and Experimental Medicine; Hospital Podlesi撤销
-
University of PittsburghMerck Sharp & Dohme LLC; Pfizer完全的
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University of Southern... 和其他合作者完全的2型糖尿病
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University of Southern... 和其他合作者完全的2型糖尿病
-
DEKK-TEC, Inc.National Cancer Institute (NCI)完全的
-
DEKK-TEC, Inc.National Cancer Institute (NCI)完全的
-
The Cleveland ClinicCase Western Reserve University完全的
-
Boston Medical CenterNational Institutes of Health (NIH); United States Agency for International Development (USAID)完全的
-
Octapharma完全的显着出血风险俄罗斯联邦, 美国, 罗马尼亚, 乌克兰, 白俄罗斯, 保加利亚, 乔治亚州, 德国, 摩尔多瓦共和国, 波兰, 西班牙